Cell-free DNA from karonudib-treated mesothelioma cells was able to activate NFkB (previously shown to mediate the transcription of M1-associated genes) [30] through Tthe LR9 receptor of macrophages, whereas the respective cell-free DNA from vehicle-treated ones could not. The gene discussed is NFKB1; the disease is mesothelioma.